Predictions related to trough and peak capillary plasma concentration of PQ at steady-state with various chemoprevention regimens of DP in 1–2 year olds weighing ≥ 11 kg.

<p>Predictions related to trough and peak capillary plasma concentration of PQ at steady-state with various chemoprevention regimens of DP in 1–2 year olds weighing ≥ 11 kg.</p

Comparative predicted capillary plasma PQ concentrations with and without a loading dose of DP and predicted maximum concentration with a loading dose of DP in 1–2 year olds weighing ≥ 11 kg.

<p>Comparative predicted capillary plasma PQ concentrations with and without a loading dose of DP and predicted maximum concentration with a loading dose of DP in 1–2 year olds weighing ≥ 11 kg.</p

DP weight-based dosing guidelines.

<p>DP weight-based dosing guidelines.</p

MOESM1 of Clinical consequences of submicroscopic malaria parasitaemia in Uganda

Additional file 1. Association between parasitaemia and documented fever

Who influences windpower licensing decisions in Norway? Formal requirements and informal practices

Implementation of the mediation analysis. (PDF 280 kb

Cytokine and Clinical Data.xls

Plasma Cytokine concentrations during an acute malaria episode and clinical data from a small nested sub-study of children in Nagongera, Uganda. Comparisons across age and by parasite density. <br

Prevalence of parasitemia (blood slide positive) by age, in three different epidemiological settings in Uganda.

<p>Prevalence of parasitemia (blood slide positive) by age, in three different epidemiological settings in Uganda.</p

Map of study sites in Uganda.

<p>Map of study sites in Uganda.</p

Prevalence of anemia (hemoglobin < 11.0 g/dL) by age, in three different epidemiological settings in Uganda.

<p>Prevalence of anemia (hemoglobin < 11.0 g/dL) by age, in three different epidemiological settings in Uganda.</p

Seroconversion to AMA-1and MSP-1₁₉ by age, in three different epidemiological settings in Uganda.

<p>Seroconversion to AMA-1and MSP-1₁₉ by age, in three different epidemiological settings in Uganda.</p